Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 10
Submit an article Journal homepage
332
Views
12
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comments on Initial experience with teriparatide in the United States

Kristine D. Harper Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA
,
John H. Krege Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA
,
Robert Marcus Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA
&
Bruce H. Mitlak Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, USA
Page 1927 | Accepted 04 Aug 2006, Published online: 29 Aug 2006

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Paul D. Miller. (2016) Management of severe osteoporosis. Expert Opinion on Pharmacotherapy 17:4, pages 473-488.
Read now
Natalie E. Cusano & John P. Bilezikian. (2011) Combination antiresorptive and osteoanabolic therapy for osteoporosis: We are not there yet. Current Medical Research and Opinion 27:9, pages 1705-1707.
Read now
Claudia Gagnon, Vivien Li & Peter R Ebeling. (2008) Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Clinical Interventions in Aging 3:4, pages 635-645.
Read now

Articles from other publishers (9)

Dragana Nikitovic, Rafaela‑Maria Kavasi, Aikaterini Berdiaki, Dionysios Papachristou, John Tsiaoussis, Demetrios Spandidos, Aristides Tsatsakis & George Tzanakakis. (2016) Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review). Oncology Reports.
Crossref
Natalie E. Cusano & John P. Bilezikian. (2012) Combination Anabolic and Antiresorptive Therapy for Osteoporosis. Endocrinology and Metabolism Clinics of North America 41:3, pages 643-654.
Crossref
V. Subbiah, V. S. Madsen, A. K. Raymond, R. S. Benjamin & J. A. Ludwig. (2009) Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporosis International 21:6, pages 1041-1045.
Crossref
Monica Girotra, Felicia Cosman & John P. Bilezikian. 2010. Osteoporosis in Men. Osteoporosis in Men 681 689 .
John P. Bilezikian. 2010. Osteoporosis. Osteoporosis 511 526 .
J. M. Hock. 2010. Osteoporosis. Osteoporosis 487 510 .
Stephanie K.A. Blick, Sohita Dhillon & Susan J. Keam. (2009) Spotlight on Teriparatide in Osteoporosis†. BioDrugs 23:3, pages 197-199.
Crossref
Jeffrey Stroup, Michael P. Kane & Asim M. Abu-Baker. (2008) Teriparatide in the treatment of osteoporosis. American Journal of Health-System Pharmacy 65:6, pages 532-539.
Crossref
John P. Bilezikian. (2008) Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window. Current Osteoporosis Reports 6:1, pages 24-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.